Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
DSP-2342 by Sumitomo Pharma America for Unspecified Psychiatric Disorders: Likelihood of Approval
DSP-2342 is under clinical development by Sumitomo Pharma America and currently in Phase I for Unspecified Psychiatric Disorders. According to...